Levonest Kit
NDC Package 50090-2505-0

11-digit billing NDC: 50090250500 · Billing unit: EA · 1 EA per package

Package Information

Levonest (levonorgestrel and ethinyl estradiol) kits is oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.Oral contraceptives are highly effective. This formulation utilizes a kit delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-2505 and is authorized under FDA application ANDA090719.

Identification & Billing

NDC Package Code
50090-2505-0
Package Description
1 KIT in 1 KIT
Product Code
11-Digit Billing Format
50090250500
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 1095227 - {6 (ethinyl estradiol 0.03 MG / levonorgestrel 0.05 MG Oral Tablet) / 10 (ethinyl estradiol 0.03 MG / levonorgestrel 0.125 MG Oral Tablet) / 5 (ethinyl estradiol 0.04 MG / levonorgestrel 0.075 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Levonest 28 Day]
  • RxCUI: 1095227 - LEVONEST 28 Day Triphasic Pack
  • RxCUI: 1095227 - Levonest 28 Day Pack
  • RxCUI: 310230 - ethinyl estradiol 0.03 MG / levonorgestrel 0.05 MG Oral Tablet
  • RxCUI: 348804 - ethinyl estradiol 0.03 MG / levonorgestrel 0.125 MG Oral Tablet

Clinical Specifications

Proprietary Name
Levonest
Non-Proprietary Name
Levonorgestrel And Ethinyl Estradiol
Dosage Form
Kit - A packaged collection of related material.
Usage Information
Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.Oral contraceptives are highly effective. Table II lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization and the IUD, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates.TABLE II: PERCENTAGE OF WOMEN EXPERIENCING AN UNINTENDED PREGNANCY DURING THE FIRST YEAR OF USE OF A CONTRACEPTIVE METHODMethodPerfect UseTypical UseLevonorgestrel implants0.050.05Male sterilization0.10.15Female sterilization0.50.5Depo-Provera®(injectable progestogen)0.30.3Oral contraceptives5Combined0.1NAProgestin only0.5NAIUDProgesterone1.52.0Copper T 380A0.60.8Condom (male) without spermicide314(Female) without spermicide521Cervical capNulliparous women920Parous women2640Vaginal spongeNulliparous women920Parous women2040Diaphragm withspermicidal cream or jelly620Spermicides alone(foam, creams, jellies, and vaginal suppositories)626Periodic abstinence (all methods)1-9*25Withdrawal419No contraception (planned pregnancy)8585NA – not available*Depending on method (calendar, ovulation, symptothermal, post-ovulation) Adapted from Hatcher RA et al, Contraceptive Technology: 17th Revised Edition. NY, NY: Ardent Media, Inc., 1998

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
Product Type
Human Prescription Drug
FDA Application #
ANDA090719
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-29-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-2505-0 identifies a specific commercial package of 1 kit in 1 kit of Levonest, a human prescription drug labeled by A-s Medication Solutions. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on December 29, 2010. The current certification is valid through December 31, 2026.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090250500. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-2505-0
11-Digit CMS (5-4-2)
50090-2505-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.